Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming

Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the...

Full description

Saved in:
Bibliographic Details
Published inEMBO molecular medicine Vol. 9; no. 6; pp. 733 - 736
Main Authors de Lázaro, Irene, Cossu, Giulio, Kostarelos, Kostas
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2017
John Wiley & Sons, Inc
EMBO Press
John Wiley and Sons Inc
Springer Nature
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. Graphical Abstract de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term in vivo OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas.
AbstractList Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc ( OSKM ) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine.
Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine.
Reprogramming adult, fully differentiated cells to pluripotency via , , and (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa-Belmonte laboratory described a cyclic regime for short-term OSKM expression that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of reprogramming in regenerative medicine.
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c-Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa-Belmonte laboratory described a cyclic regime for short-term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine.
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. Graphical Abstract de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term in vivo OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas.
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused by sustained reprogramming, which precludes the therapeutic translation of this technology. A recent study by the Izpisúa‐Belmonte laboratory described a cyclic regime for short‐term OSKM expression in vivo that prevents complete reprogramming to the pluripotent state as well as tumorigenesis. We comment here on this and other studies that provide evidence that in vivo OSKM induction can enhance tissue regeneration, while avoiding the feared formation of teratomas. These results could inspire more research to explore the potential of in vivo reprogramming in regenerative medicine. de Lázaro, Cossu and Kostarelos comment on the prospects of short‐term in vivo OSKM induction to initiate cell reprogramming and enhance tissue regeneration, while avoiding the threat of generating teratomas.
Audience Academic
Author Kostarelos, Kostas
de Lázaro, Irene
Cossu, Giulio
AuthorAffiliation 1 Nanomedicine Lab Faculty of Biology, Medicine and Health The University of Manchester Manchester UK
2 Division of Cell Matrix Biology & Regenerative Medicine Faculty of Biology, Medicine and Health The University of Manchester Manchester UK
AuthorAffiliation_xml – name: 1 Nanomedicine Lab Faculty of Biology, Medicine and Health The University of Manchester Manchester UK
– name: 2 Division of Cell Matrix Biology & Regenerative Medicine Faculty of Biology, Medicine and Health The University of Manchester Manchester UK
Author_xml – sequence: 1
  givenname: Irene
  surname: de Lázaro
  fullname: de Lázaro, Irene
  organization: Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester
– sequence: 2
  givenname: Giulio
  orcidid: 0000-0001-5863-9593
  surname: Cossu
  fullname: Cossu, Giulio
  organization: Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester
– sequence: 3
  givenname: Kostas
  orcidid: 0000-0002-2224-6672
  surname: Kostarelos
  fullname: Kostarelos, Kostas
  organization: Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28455313$$D View this record in MEDLINE/PubMed
BookMark eNqFks1uEzEUhUeoiP7Amh0aiQ0sktoe_8ywQKqqAhWNuqCsLY_nenCYsYM9Scnb8Cw8GU6mhEQCIS9s2ed8vtc-p9mR8w6y7DlGU8wII-fQ9_2UICyQ4Aw9yk6wYGJCeUmPdmvBj7PTGOcIccZx-SQ7JiVlrMDFSRbvgnLRghvyYbPSwS4G611ulB58yF_dfvo4e53D90WAGDcHNuZfYZ0P_l6FJua6s85q1Y32Tm3N3uTW_fyxsiufa-i6PMAi-DaovreufZo9NqqL8OxhPss-v7u6u_wwubl9f315cTPRnHI04aKmhhCAsgLWlA3XoFNfosLYcABNENGgtCaa1KhEqMDMFBUoQUiJm7opzrLrkdt4NZeLYHsV1tIrK7cbPrRShcHqDqRhUABhSot0N9CiKnRjaqNKxEoohEistyNrsax7aHR6sKC6A-jhibNfZOtXklFGEOUJ8PIBEPy3JcRBzv0yuNS_xBWiSFBC8R9Vq1JV1hmfYLq3UcuL9MGC0IrRpJr-RZVGA73VKSHGpv0Dw_lo0MHHGMDsCsdIboMkN0GSuyAlx4v9fnf638lJgjej4D7dtf4fT17NZrN9OhrNMflcC2HvMf5R0C80HOlw
CitedBy_id crossref_primary_10_1007_s12035_018_0888_0
crossref_primary_10_1177_0024363920926013
crossref_primary_10_1016_j_ymthe_2018_10_014
crossref_primary_10_1038_s41467_018_05059_x
crossref_primary_10_1159_000539415
crossref_primary_10_3389_fgene_2024_1389558
crossref_primary_10_1186_s13287_019_1165_5
crossref_primary_10_1002_adtp_202000141
crossref_primary_10_1080_10409238_2019_1570075
crossref_primary_10_2174_1566523219666190902154511
crossref_primary_10_1186_s13287_018_1075_y
crossref_primary_10_1016_j_gde_2023_102067
crossref_primary_10_1038_s12276_022_00880_3
crossref_primary_10_1089_cell_2023_0123
crossref_primary_10_1016_j_colsurfb_2021_111991
crossref_primary_10_1111_acel_13764
crossref_primary_10_1002_stem_2842
Cites_doi 10.1016/j.cell.2006.07.024
10.1038/nature12586
10.1038/srep22490
10.1126/science.aaf4445
10.1371/journal.pone.0054754
10.1042/BST20140012
10.1016/j.cell.2014.01.005
10.1101/101188
10.1016/j.ymgme.2008.12.016
10.1016/j.stem.2016.11.020
10.1016/j.cell.2016.11.052
ContentType Journal Article
Copyright The Authors. Published under the terms of the CC BY 4.0 license 2017
2017 The Authors. Published under the terms of the CC BY 4.0 license
2017 The Authors. Published under the terms of the CC BY 4.0 license.
COPYRIGHT 2017 John Wiley & Sons, Inc.
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Authors. Published under the terms of the CC BY 4.0 license 2017
– notice: 2017 The Authors. Published under the terms of the CC BY 4.0 license
– notice: 2017 The Authors. Published under the terms of the CC BY 4.0 license.
– notice: COPYRIGHT 2017 John Wiley & Sons, Inc.
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.15252/emmm.201707650
DatabaseName SpringerOpen
Wiley Open Access
Wiley Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Biological Science Database
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList

MEDLINE
Publicly Available Content Database



CrossRef
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: 24P
  name: Wiley-Blackwell Open Access Collection
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 4
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 5
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 6
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate Irene de Lázaro et al
EISSN 1757-4684
EndPage 736
ExternalDocumentID oai_doaj_org_article_f5e3e25ac7c64e4393cdfbfa8058e377
A765724954
10_15252_emmm_201707650
28455313
EMMM201707650
Genre commentary
Comment
Journal Article
Commentary
GroupedDBID ---
0R~
1OC
24P
4.4
53G
5DZ
5GY
5VS
7X7
8-0
8-1
8AO
8FE
8FH
8FI
8FJ
AAHHS
AAZKR
ABJNI
ABOCM
ABUWG
ACCFJ
ACGFO
ACGFS
ACPRK
ACXQS
ADBBV
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AEGXH
AENEX
AEQDE
AFBPY
AFKRA
AHMBA
AIAGR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BTFSW
BVXVI
C6C
CCPQU
D-9
DIK
DU5
EBD
EBS
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HK~
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
LH4
LK8
LW6
M48
M7P
M~E
NNB
O9-
OIG
OK1
OVD
OVEED
P2P
PIMPY
PQQKQ
PROAC
RHF
RHI
RNS
ROL
RPM
SV3
TEORI
UKHRP
WIN
XV2
31~
ACSMW
AFZJQ
EBLON
GODZA
H13
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
AEUQT
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c6460-67b4f22ee89e5d8d6cec6847911f6eec202ceacc2c2b0800315f39ea72281dbd3
IEDL.DBID RPM
ISSN 1757-4676
IngestDate Mon Oct 21 19:39:29 EDT 2024
Tue Sep 17 21:15:27 EDT 2024
Thu Oct 10 20:47:08 EDT 2024
Fri Feb 23 00:21:20 EST 2024
Wed Nov 13 00:01:16 EST 2024
Thu Sep 26 15:40:55 EDT 2024
Sat Sep 28 08:30:23 EDT 2024
Sat Aug 24 00:52:23 EDT 2024
Sat Oct 19 01:30:56 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Attribution
2017 The Authors. Published under the terms of the CC BY 4.0 license.
This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6460-67b4f22ee89e5d8d6cec6847911f6eec202ceacc2c2b0800315f39ea72281dbd3
ORCID 0000-0001-5863-9593
0000-0002-2224-6672
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452046/
PMID 28455313
PQID 1904074241
PQPubID 866378
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_f5e3e25ac7c64e4393cdfbfa8058e377
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5452046
proquest_journals_1904074241
gale_infotracmisc_A765724954
gale_infotracacademiconefile_A765724954
crossref_primary_10_15252_emmm_201707650
pubmed_primary_28455313
wiley_primary_10_15252_emmm_201707650_EMMM201707650
springer_journals_10_15252_emmm_201707650
PublicationCentury 2000
PublicationDate June 2017
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: June 2017
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: Frankfurt
– name: Hoboken
PublicationTitle EMBO molecular medicine
PublicationTitleAbbrev EMBO Mol Med
PublicationTitleAlternate EMBO Mol Med
PublicationYear 2017
Publisher Nature Publishing Group UK
John Wiley & Sons, Inc
EMBO Press
John Wiley and Sons Inc
Springer Nature
Publisher_xml – name: Nature Publishing Group UK
– name: John Wiley & Sons, Inc
– name: EMBO Press
– name: John Wiley and Sons Inc
– name: Springer Nature
References Abad, Mosteiro, Pantoja, Canamero, Rayon, Ors, Grana, Megias, Dominguez, Martinez (CR1) 2013; 502
CR6
Takahashi, Yamanaka (CR9) 2006; 126
CR5
Wilson (CR10) 2009; 96
Ocampo, Reddy, Martinez‐Redondo, Platero‐Luengo, Hatanaka, Hishida, Li, Lam, Kurita, Beyret (CR7) 2016; 167
de Lazaro, Kostarelos (CR4) 2014; 42
Yilmazer, de Lazaro, Bussy, Kostarelos (CR11) 2013; 8
Ohnishi, Semi, Yamamoto, Shimizu, Tanaka, Mitsunaga, Okita, Osafune, Arioka, Maeda (CR8) 2014; 156
Chiche, Le Roux, von Joest, Sakai, Aguin, Cazin, Salam, Fiette, Alegria, Flamant (CR2) 2016; 20
Gao, Wang, Xiong, Chen (CR3) 2016; 6
2016; 20
2016; 354
2016; 167
2016; 6
2017
2009; 96
2006; 126
2013; 8
2014; 156
2013; 502
2014; 42
27984723 - Cell. 2016 Dec 15;167(7):1719-1733.e12
e_1_2_4_10_1
e_1_2_4_11_1
e_1_2_4_12_1
e_1_2_4_3_1
e_1_2_4_2_1
e_1_2_4_5_1
e_1_2_4_4_1
e_1_2_4_7_1
e_1_2_4_6_1
e_1_2_4_9_1
e_1_2_4_8_1
References_xml – volume: 167
  start-page: 1719
  year: 2016
  end-page: 1733
  ident: CR7
  article-title: amelioration of age‐associated hallmarks by partial reprogramming
  publication-title: Cell
  contributor:
    fullname: Beyret
– volume: 8
  start-page: e54754
  year: 2013
  ident: CR11
  article-title: cell reprogramming towards pluripotency by virus‐free overexpression of defined factors
  publication-title: PLoS ONE
  contributor:
    fullname: Kostarelos
– ident: CR6
– volume: 156
  start-page: 663
  year: 2014
  end-page: 677
  ident: CR8
  article-title: Premature termination of reprogramming leads to cancer development through altered epigenetic regulation
  publication-title: Cell
  contributor:
    fullname: Maeda
– volume: 502
  start-page: 340
  year: 2013
  end-page: 345
  ident: CR1
  article-title: Reprogramming produces teratomas and iPS cells with totipotency features
  publication-title: Nature
  contributor:
    fullname: Martinez
– ident: CR5
– volume: 20
  start-page: 407
  year: 2016
  end-page: 414
  ident: CR2
  article-title: Injury‐induced senescence enables reprogramming in skeletal muscle
  publication-title: Cell Stem Cell
  contributor:
    fullname: Flamant
– volume: 42
  start-page: 711
  year: 2014
  end-page: 716
  ident: CR4
  article-title: cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration
  publication-title: Biochem Soc Trans
  contributor:
    fullname: Kostarelos
– volume: 6
  start-page: 22490
  year: 2016
  ident: CR3
  article-title: reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury
  publication-title: Sci Rep
  contributor:
    fullname: Chen
– volume: 96
  start-page: 151
  year: 2009
  end-page: 157
  ident: CR10
  article-title: Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
  publication-title: Mol Genet Metab
  contributor:
    fullname: Wilson
– volume: 126
  start-page: 663
  year: 2006
  end-page: 676
  ident: CR9
  article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
  publication-title: Cell
  contributor:
    fullname: Yamanaka
– volume: 502
  start-page: 340
  year: 2013
  end-page: 345
  article-title: Reprogramming produces teratomas and iPS cells with totipotency features
  publication-title: Nature
– volume: 20
  start-page: 407
  year: 2016
  end-page: 414
  article-title: Injury‐induced senescence enables reprogramming in skeletal muscle
  publication-title: Cell Stem Cell
– volume: 126
  start-page: 663
  year: 2006
  end-page: 676
  article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
  publication-title: Cell
– volume: 6
  start-page: 22490
  year: 2016
  article-title: reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury
  publication-title: Sci Rep
– volume: 167
  start-page: 1719
  year: 2016
  end-page: 1733
  article-title: amelioration of age‐associated hallmarks by partial reprogramming
  publication-title: Cell
– year: 2017
  article-title: Non‐viral induction of transient cell reprogramming in skeletal muscle to enhance tissue regeneration
  publication-title: bioRxiv
– volume: 42
  start-page: 711
  year: 2014
  end-page: 716
  article-title: cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration
  publication-title: Biochem Soc Trans
– volume: 96
  start-page: 151
  year: 2009
  end-page: 157
  article-title: Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
  publication-title: Mol Genet Metab
– volume: 8
  start-page: e54754
  year: 2013
  article-title: cell reprogramming towards pluripotency by virus‐free overexpression of defined factors
  publication-title: PLoS ONE
– volume: 354
  year: 2016
  article-title: Tissue damage and senescence provide critical signals for cellular reprogramming
  publication-title: Science
– volume: 156
  start-page: 663
  year: 2014
  end-page: 677
  article-title: Premature termination of reprogramming leads to cancer development through altered epigenetic regulation
  publication-title: Cell
– ident: e_1_2_4_10_1
  doi: 10.1016/j.cell.2006.07.024
– ident: e_1_2_4_2_1
  doi: 10.1038/nature12586
– ident: e_1_2_4_4_1
  doi: 10.1038/srep22490
– ident: e_1_2_4_7_1
  doi: 10.1126/science.aaf4445
– ident: e_1_2_4_12_1
  doi: 10.1371/journal.pone.0054754
– ident: e_1_2_4_5_1
  doi: 10.1042/BST20140012
– ident: e_1_2_4_9_1
  doi: 10.1016/j.cell.2014.01.005
– ident: e_1_2_4_6_1
  doi: 10.1101/101188
– ident: e_1_2_4_11_1
  doi: 10.1016/j.ymgme.2008.12.016
– ident: e_1_2_4_3_1
  doi: 10.1016/j.stem.2016.11.020
– ident: e_1_2_4_8_1
  doi: 10.1016/j.cell.2016.11.052
SSID ssj0065618
Score 2.310632
Snippet Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various...
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various...
Reprogramming adult, fully differentiated cells to pluripotency via , , and (OSKM) overexpression has proved feasible in various independent studies and could...
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc ( OSKM ) overexpression has proved feasible in...
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various...
Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c-Myc (OSKM) overexpression has proved feasible in various...
Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4, Sox2, Klf4 and c‐Myc (OSKM) overexpression has proved feasible in...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
wiley
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 733
SubjectTerms Adult
c-Myc protein
Cell Differentiation
Cellular Reprogramming
Commentaries
Commentary
EMBO34
EMBO39
Gene Expression Regulation
Humans
KLF4 protein
Myc protein
Oct-4 protein
Octamer Transcription Factor-3 - genetics
Pluripotency
Regenerative medicine
SOXB1 Transcription Factors - genetics
Tissue engineering
Transcription Factors
Translation
Tumorigenesis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hSiAuCMorUJAPSLSHqIlfyR4LalWBAgeo1JuVOBOxh81W7FLBv-G38MuYsZNoA0K9cNtNvBtnnp_teQC8wqzmum42xbJQqda80USwNKXRSNfJaCKf6FYf7PmFfndpLndafXFMWCwPHAl33BlUKE3tC281kvtUvu2ari4zU6IqYh55thgXU9EGE0gJO3vkG4uUTIEdivoYaeQxrlacgp4XtITndPsdfxTK9v9tnHe805-Rk9Px6RzcBu90dh_uDbBSnMTXeQC3sN-H27HR5I99uFMNR-gPYRO8E2dBii1_Gq2GiJ13xOHHT--rI4HfhwjZXiw3gjRdbEOA7UaMuZTx5zGUTqw7sex__bxeXq8FnwUILpYZIr9WNO9HcHF2-vnteTp0XkiJyJbzARrdSYlYLtC0ZWs9ekt-jCxjZxG9zKQni-2llw1DTpWbTi2wLqQk_Nu06jHs9esen4IwRllvCqkbo8gRqsbmXVbUtZdl2xjtEzgc6e-uYoENxwsTZpVjVrmJVQm8Yf5Mw7gydrhA8uIGeXE3yUsCr5m7jvWX6OTrIQ2BZsuVsNwJPanghtw6gYPZSNI7P789yocb9H7jCF5p3m3QeQJPoqhM0yUgQMTIVQLFTIhm7zO_0y-_hIrf3Ag-0zaBo1Hcdh75L2KpII83EdWdVlU1fXv2P0j8HO7yH8aAugPY2379hi8Ium2bl0FLfwNFXz4z
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtQw1IIiEBcEZQsU5AMS7SFq4jU9oYJaVaDAASrNzUqcF5jDZMrMtCp_z3uOEyYg4JbFUey3229j7BVkFdV1MykUVqZK0UETmqUpjgZ8jkITyKNbfjRn5-r9TM_igds6hlUOMjEI6mbp6Yz8EBWXon2cyt9cfE-paxR5V2MLjZvsVi4yQyFddjZuuNBUCed7qCFtigLBxNI-WmhxCIsFJaLnFjfylHS_pZVC8f4_RfSWjvo9fnJ0ok5N3KCjTu-ze9G45Mc9NTxgN6DbZbf7dpM_dtmdMjrSH7JV0FGUC8k3dDXIDt733-H7nz5_KA84XMc42Y7P1xz5nW9CmO2aDxmV_ed9QB1ftnze8av51ZKTQ4BTxcwQ_rXAaT9i56cnX96dpbH9QuqNMpQUUKtWCIDiCHRTNMaDN6jMUDy2BsCLTHgU2154UZPdKXPdyiOorBBoBNeNfMx2umUHTxnXWhqvrVC1lqgNZW3yNrNV5UXR1Fr5hO0P4HcXfZUNR7sTwpQjTLkRUwl7S-gZh1F57PBgufrqIre5VoMEoStvcSmANpf0TVu3VZHpAqS1CXtNyHXExAgmX8VcBJwtlcNyx_gnS125VcL2JiOR-fz09UAeLjL_2v0i1YQ96SllnC5aAwiMXCbMTmhosp7pm27-LZT9pm7wmTIJOxiobeuXfwOWDOT4P6C6k7Isx7tn_17Uc3aXhvbxcntsZ7O6hBdomW3ql4H9fgLAOzNk
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1JbtRAsISCQFwQhM0hoD4gkRwM416dA0IBJYpAhgOMlFvLbpdhJMZDZoYo-Q1v4WVUeSOGRNy8tOV27eXaAJ7hJOe-bjbG1KlYa_7RRGZpTKuRrpPQRI7oZh_s0VS_OzbHf8YBdQBcXera8Typ6fLbi7OT89fE8K-66T3yJc7nXFSeOHLK2X-_LjW56ZzHp4eQAtktSdr19rnkIW4KnGpDFKlGGqpp5P-vuL6gr_7OpRwCqmNzt9FXh3fgdmdoiv2WMu7CNaw34UY7evJ8E25mXVD9HqwafcV1kWLNR70cEe0sHrHz8dP7bFfgWZczW4vZShDvi3WTcrsSfXVl-3ibXCcWlZjVv36ezk4XgqMDgttnNrlgc9r3fZgeHnx-exR3sxjiYLXlCoFCV1IipntoyrS0AYMlzUaysrKIQU5kIBkeZJAFG6EqMZXaw9xJSRZxUaoHsFEvanwEgoBsg3FSF0aRalSFTaqJy_Mg07IwOkSw08Pff29bbnh2VRhrnrHmB6xF8IbxMyzjXtnNhcXyi-9Yz1cGFUqTB0efgmSAqVBWRZWnE5Oici6C54xdzzRGcAp5V5hAu-XeWH6f3uR4RLeOYHu0kjgxjG_39OF7QvZkcGn-_6CTCB62pDJst6e4CNyIiEbfM75Tz742PcB5NPxE2wh2e3K78MqrgKUaevwfUP1BlmXD2daVu34Mt3hVmze3DRvr5Q98QhbaunjacN5v95Y12w
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3JbtQw9AkVgbggKFugIB-QaA8Ridf0WEatKlDgAJV6sxLnRcxhMogZKvgbvoUv4z1n0YRFiFsSO7HzdttvAXiOWcV53WyKhVOp1rzRRGZpSr2RnpPQRD7RLd_a8wv9-tJcDkmSOBZm9_zeSCNf4mrFAeO5owU3r82vkwIu2HdrYRejyCWbJG7kkSp0KXG-HXL4_OEDM_UTs_T_Lot3lNGvjpLTaenclo3K6OwO3B6sSHHSo_0uXMNuH270dSW_7cPNcjgxvwebqIw46FFs-WoUEqIvtCMO371_Ux4J_Do4xHZiuRHE2GIb_Wk3Ygyd7F_vPefEuhXL7sf3q-XVWvDWv-DcmNHRa0Xzvg8XZ6cfFufpUGghDVZbdv-vdSslYnGMpikaGzBYUlskCFuLGGQmAwnoIIOs2cJUuWnVMVZOSjJ360Y9gL1u3eEjEMYoG4yTujaK9J6qbd5mrqqCLJra6JDA4Qh__6nPp-F5HcKo8owqP6EqgVeMn6kbJ8KOD4g-_MBXvjWoUJoqOPoVJOtKhaat26rITIHKuQReMHY9syvBKVRD1AHNlhNf-RMayXH9bZ3AwawnsVmYN4_04Qc233iypjRvLug8gYc9qUzTJb1PwMhVAm5GRLP_mbd0y48xwTfXfc-0TeBoJLedIf8GLBXp8V9A9adlWU53j_9jhCdwi697N7kD2Nt-_oJPySDb1s8iM_4E8qctUg
  priority: 102
  providerName: Springer Nature
– databaseName: Wiley Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB6kovgiWm_RKvsg2D4Ek72mj1VaihIVtODbkmwmeh5OjjTHov_G3-Ivc2ZzoVFE8C2XTbKZndvuznwD8BSzinHdbIqFU6nWvNBEbmlKrZGuk9JE3tEt39jTM_3qo5miCTkXZsCHmBfcWDKivmYBr-p-qtjDqKG4XnMqee5oKs6z9quMG8Pw-VK_m5QxeStxiY-MpEtJJ9gR3Ydf8Xz5goVhivj9f2rpS2bq9xDKeR916eVGM3VyC26O_qU4GhjiNlzBbheuDRUnv-_C9XLcS78DfTRTnA4ptnw0qQ8xlOAR-2_fvy4PBH4bQ2U7seoFibzYxkjbXkxJlcPjQ0yd2LRi1f38cbG62AjeFBCMmhlDwNbU77twdnL84eVpOpZgSIPVlhMDat1KiVgcommKxgYMlgwaqcjWIgaZyUCqO8gga_Y9VW5adYiVk5Ic4bpR92Cn23T4AIQxygbjpK6NIouoapu3mauqIIumNjoksD_R338ZkDY8z1B4qDwPlZ-HKoEXPD5zM4bIjhc255_8KHG-NahQmio4-hUkv0uFpq3bqshMgcq5BJ7x6HoWZKJTqMZ8BOotQ2L5I_qS48rcOoG9RUsSwLC8PfGHHxVA78nP0rzsoPME7g-sMneXPAIiRq4ScAsmWvzP8k63-hyhv7kifKZtAgcTu1365N-IpSI__ouo_rgsy_ns4X899Qhu8PEQSrcHO9vzr_iYnLZt_SSK5S_LDTjZ
  priority: 102
  providerName: Wiley-Blackwell
Title Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming
URI https://link.springer.com/article/10.15252/emmm.201707650
https://onlinelibrary.wiley.com/doi/abs/10.15252%2Femmm.201707650
https://www.ncbi.nlm.nih.gov/pubmed/28455313
https://www.proquest.com/docview/1904074241
https://pubmed.ncbi.nlm.nih.gov/PMC5452046
https://doaj.org/article/f5e3e25ac7c64e4393cdfbfa8058e377
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bbtMw9GgdAu0FwbgFRuUHJLaHrK2v2eNWdZpAGRUwqW9W4jojEk2ntZvgb_gWvoxznKRaQAiJlygXJ7HP3fa5ALzxw4zyuunYJ0bEUtJCE5qlMbb2eB-Fpqcd3fRcn13IdzM12wLVxsIEp32Xl4fV18VhVX4JvpVXCzdo_cQG03RMdbFpa7IHPSTQdopei1-0T8KiHqpFE6MU0E0-H8UVH_jFgqLPRwZn74qKwKFwVkiFoqOVQvL-P0X0HR31u__kZhO1a-IGHXX6CB42xiU7rgfxGLZ8tQv363KT33fhQdpspD-BVdBRFAvJ1nTWyg5W199h-x8-vU8PmP_W-MlWrFwx5He2Dm62K9ZGVNav1w51bFmwsvr547a8XTLaEWCUMjP4fy2w30_h4nTyeXwWN_UXYqelpqiAXBace58ceTVP5tp5p1GboXwstPeOD7lDue244zkZnmKkCnHkM8M5WsH5XDyD7WpZ-RfAEMjaKcNlrgSqQ5HrUTE0WeZ4Ms-VdBHst_C3V3WaDUvTE8KaJazZDdYiOCH8bJpRfuxwY3l9aRsqsYXywnOVOYND8Wh0CTcv8iJLhirxwpgI3hJ2LXExwsllTTAC9pbyYdlj_JOhstwygr1OS-Q-133c0odtuH9l0ciStOYgRxE8r0ll092W4iIwHSLqjKf7BNkg5P1uyD6Cg5bc7vzyb8ASgR7_BVQ7SdN0c_Xyv_v2CnboK7Uv3R5sr69v_Gu02tZ5H3pcTvFoZqYP904m59OPeDXW435YB8FjKpN-4OVftSBDpw
link.rule.ids 230,315,730,783,787,867,888,2109,2228,11574,12068,21400,24330,27936,27937,31731,33756,41132,42201,43322,43817,46064,46488,50826,50935,51588,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtQw9AmKWC4IyhYo4AMS7SHqjNf0hApqNdCmHGiluVmJ48AcJlNmhgr-nvccJ0xAwC2Lo9hvt98G8MqPCqrrplOfGZFKSQdNaJamONrjcxSanjy6-ZmeXMgPUzWNB26rGFbZycQgqKuFozPyfVRckvZxcvzm8mtKXaPIuxpbaFyHG1SHizoYmGm_4UJTJZzvoYY0KQoEHUv7KK74vp_PKRF9bHAjT0n3G1opFO__U0Rv6Kjf4yd7J-rQxA066vge3I3GJTtsqeE-XPPNNtxs203-2IZbeXSkP4Bl0FGUC8nWdNXJDtb232G7Hz-d5HvMf49xsg2brRjyO1uHMNsV6zIq28_bgDq2qNmsYVezqwUjhwCjipkh_GuO034IF8dH5-8maWy_kDotNSUFlLLm3PvswKsqq7TzTqMyQ_FYa-8dH3GHYttxx0uyO8VY1eLAF4ZzNILLSjyCrWbR-CfAlBLaKcNlqQRqQ1HqcT0yReF4VpVKugR2O_Dby7bKhqXdCWHKEqZsj6kE3hJ6-mFUHjs8WCw_28httlZeeK4KZ3ApHm0u4aq6rItspDIvjEngNSHXEhMjmFwRcxFwtlQOyx7inwx15ZYJ7AxGIvO54euOPGxk_pX9RaoJPG4ppZ8uWgMIjLFIwAxoaLCe4Ztm9iWU_aZu8COpE9jrqG3jl38Dlgjk-D-g2qM8z_u7p_9e1Eu4PTnPT-3p-7OTZ3CHPmtj53Zga7385p-jlbYuXwRW_AlAQTZL
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3JbtNA9AlSUXFBUDZDgTkg0R6sOrO6J9RCokJxqIBKvY3s8RhyiFOSUMHf8549DjEIuHkZyzNvn3kbwHOf5FTXTcc-NSKWkg6a0CyNcbTH5yg0PXl0s4k-OZdvL9RFiH9ahrDKTiY2grqcOzojP0DFJWkfJ4cHVQiLOHs9fnn5NaYOUuRpDe00rsOWkVokA9g6Hk3OPnRyGQ2X5rQP9aWJUTzoUOhHccUP_GxGaelDg9t6SsHf0FFNKf8_BfaGxvo9mnLtUu0bvI3GGt-GW8HUZEctbdyBa77egRtt88kfO7CdBbf6XVg0GosyI9mKrjpJwtpuPGzv_cfTbJ_57yFqtmbTJUPuZ6sm6HbJuvzK9vM2vI7NKzat2dX0as7IPcCofmYTDDbDad-D8_Ho06uTODRjiJ2WmlIECllx7n166FWZltp5p1G1obCstPeOJ9yhEHfc8YKsUDFUlTj0ueEcTeKiFPdhUM9r_xCYUkI7ZbgslEDdKAo9rBKT546nZaGki2CvA7-9bGtuWNqrEKYsYcquMRXBMaFnPYyKZTcP5ovPNvCerZQXnqvcGVyKRwtMuLIqqjxNVOqFMRG8IORaYmkEk8tDZgLOlopj2SP8k6Ee3TKC3d5IZEXXf92Rhw2iYGl_EW4ED1pKWU8XbQMExlBEYHo01FtP_009_dIUAafe8InUEex31Lbxy78BSzTk-D-g2lGWZeu7R_9e1DPYRj60795MTh_DTfqqDaTbhcFq8c0_QZNtVTwNvPgTb5476A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transient+transcription+factor+%28OSKM%29+expression+is+key+towards+clinical+translation+of+in%C2%A0vivo+cell+reprogramming&rft.jtitle=EMBO+molecular+medicine&rft.au=de+L%C3%A1zaro%2C+Irene&rft.au=Cossu%2C+Giulio&rft.au=Kostarelos%2C+Kostas&rft.date=2017-06-01&rft.eissn=1757-4684&rft.volume=9&rft.issue=6&rft.spage=733&rft_id=info:doi/10.15252%2Femmm.201707650&rft_id=info%3Apmid%2F28455313&rft.externalDocID=28455313
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-4676&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-4676&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-4676&client=summon